A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples